Regardless, we could speculate that the beneficial effects associated with STAT3 blockade in the muscle of animals bearing highly inflammatory tumors (such the C26 colorectal adenocarcinomas) are likely to overcome the toxicities of the drug per se. The gene discussed is STAT3; the disease is colorectal adenocarcinoma.